Large-scale Evidence Generation and Evaluation across a Network of Database for Type 2 Diabetes Mellitus (LEGEND-T2DM)
=============
<h2>PLEASE NOTE: All results are preliminary and subject to change</h2>

<hr class="w-100" style="border-top: black 1px solid;">

<h3>Terms of Use:</h3>
<p>These results are being shared as part of OHDSI's open science community efforts to study the comparative cardiovascular effectiveness and safety of treatments for diabetes under the LEGEND-T2DM initiative, for the purpose of enabling collaborative research within the community.
Synthesis of the results and interpretation of the findings is underway and manuscripts are being prepared.
All manuscripts must be reviewed and approved by all co-authors and data partner contributors prior to submission.
Until final publication, all results are to be considered preliminary and subject to change, and may only be used under the terms of use of the respective data partner contributors.</p>

**Objectives:**<br>
1) Point 1.<br>

**Resources:**<br>
- The study protocol is available <a href="https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis/blob/master/documents/Protocol_COVID-19%20Charybdis%20Characterisation_V5.docx" target="_blank">here</a>
- All analytic code is availble at <a href="https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis" target="_blank">GitHub</a>

**Cohort Diagnostics:**<br>
- <a href="https://data.ohdsi.org/Covid19CharacterizationCharybdisDiagCovid/">Class-vs-class exposure cohorts</a>
- <a href="https://data.ohdsi.org/Covid19CharacterizationCharybdisDiagInfluenza/">Outcome cohorts</a>
